26 related articles for article (PubMed ID: 12562651)
1. A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528.
Dy GK; Mandrekar SJ; Nelson GD; Meyers JP; Adjei AA; Ross HJ; Ansari RH; Lyss AP; Stella PJ; Schild SE; Molina JR; Adjei AA
J Thorac Oncol; 2013 Jan; 8(1):79-88. PubMed ID: 23232491
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) by amphotericin B in BALB/c nude mice bearing human ovarian carcinoma cells.
Kojima M; Kikkawa F; Oguchi H; Tamakoshi K; Maeda O; Suganuma N; Tomoda Y
Jpn J Cancer Res; 1994 Nov; 85(11):1159-64. PubMed ID: 7829402
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the cytotoxic activity of carboplatin and gemcitabine combination.
Wang S; Zhang H; Cheng L; Evans C; Pan CX
Anticancer Res; 2010 Nov; 30(11):4573-8. PubMed ID: 21115908
[TBL] [Abstract][Full Text] [Related]
5. A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancer.
Clément-Duchêne C; Krupitskaya Y; Ganjoo K; Lavori P; McMillan A; Kumar A; Zhao G; Padda S; Zhou L; Pedro-Salcedo MS; Colevas AD; Wakelee HA
J Thorac Oncol; 2010 Nov; 5(11):1821-5. PubMed ID: 20881641
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Jones JA; Avritscher EB; Cooksley CD; Michelet M; Bekele BN; Elting LS
Support Care Cancer; 2006 Jun; 14(6):505-15. PubMed ID: 16601950
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC.
Rocha Lima CM; Rizvi NA; Zhang C; Herndon JE; Crawford J; Govindan R; King GW; Green MR;
Ann Oncol; 2004 Mar; 15(3):410-8. PubMed ID: 14998842
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine/carboplatin in advanced non-small cell lung cancer.
Zatloukal P; Petruzelka L
Lung Cancer; 2002 Nov; 38 Suppl 2():S33-6. PubMed ID: 12431827
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.
Grigorescu AC; Draghici IN; Nitipir C; Gutulescu N; Corlan E
Lung Cancer; 2002 Jul; 37(1):9-14. PubMed ID: 12057861
[TBL] [Abstract][Full Text] [Related]
10. Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801.
Takayama K; Takeshita M; Inoue K; Ichiki M; Fujita M; Harada T; Shiraishi Y; Wataya H; Tokunaga S; Yamada T; Uchino J; Sugio K
Oncologist; 2020 Aug; 25(8):e1146-e1157. PubMed ID: 32385918
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
Binder D; Schweisfurth H; Grah C; Schäper C; Temmesfeld-Wollbrück B; Siebert G; Suttorp N; Beinert T
Cancer Chemother Pharmacol; 2007 Jun; 60(1):143-50. PubMed ID: 17031643
[TBL] [Abstract][Full Text] [Related]
12. Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer.
Takayama K; Ichiki M; Matsumoto T; Ebi N; Akamine S; Tokunaga S; Yamada T; Uchino J; Nakanishi Y
Oncologist; 2020 Mar; 25(3):208-e417. PubMed ID: 32162814
[TBL] [Abstract][Full Text] [Related]
13. Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
Paccagnella A; Oniga F; Bearz A; Favaretto A; Clerici M; Barbieri F; Riccardi A; Chella A; Tirelli U; Ceresoli G; Tumolo S; Ridolfi R; Biason R; Nicoletto MO; Belloni P; Veglia F; Ghi MG
J Clin Oncol; 2006 Feb; 24(4):681-7. PubMed ID: 16446341
[TBL] [Abstract][Full Text] [Related]
14. Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer.
Bajetta E; Stani SC; De Candis D; Zaffaroni N; Zilembo N; Cortinovis D; Aglione S; Mariani L; Formisano B; Bidoli P
Ann Oncol; 2003 Feb; 14(2):242-7. PubMed ID: 12562651
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
